Abstract
Use of inappropriate drugs is common among elderly. These drugs are associated with an increased risk of adverse drug reactions in older adults. Here we focus on four groups of drugs that are frequently used by older patients but should, if possible, be avoided. These groups are: benzodiazepines, antipsychotic drugs, drugs with anticholinergic effects, and non-steroidal anti-inflammatory drugs (NSAID). Benzodiazepines, anticholinergic drugs and antipsychotic drugs may cause delirium, especially in the elderly. Possible severe adverse effects from NSAIDs are e.g. gastrointestinal bleeding, renal, and heart failure. Elderly patients are more susceptible to adverse drug reactions from all these drugs due to pharmacokinetical and pharmacodynamical alterations. In most cases there are safer alternatives.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aichhorn W, Weiss U, Marksteiner J et al. (2005) Influence of age and gender on risperidone plasma concentrations. J Psychopharmacol 19(4): 395–401
Ancelin ML, Artero S, Portet F et al. (2006) Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 332: 455–459
Avorn J, Bohn RL, Mogun H et al. (1995) Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. Am J Med 99(1): 48–54
Bachman DL (1992) Sleep disorders with aging: evaluation and treatment. Geriatrics 47(9): 53–56, 59–61
Baldwin DS and Polkinghorn C (2005) Evidence-based pharmacotherapy of Generalized Anxiety Disorder. Int J Neuropsychopharmacol 8(2): 293–302
Ballard C, Hanney ML, Theodoulou M et al. (2009) The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology DOI:10.1016/S1474-4422(08)70295-3
Ballard C, Lana MM, Theodoulou M et al. (2008) A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping antipsychotics (the DART-AD trial). PLoS Med 5(4): e76
Bogunovic OJ and Greenfield SF (2004) Practical geriatrics: Use of benzodiazepines among elderly patients. Psychiatr Serv 55(3): 233–235
Brodaty H, Ames D, Snowdon J et al. (2003) A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64(2): 134–143
Carlsten A, Waern M, Holmgren P et al. (2003) The role of benzodiazepines in elderly suicides. Scand J Public Health 31(3): 224–248
Castleden CM, George CF, Marcer D et al. (1977) Increased sensitivity to nitrazepam in old age. Br Med J 1(6052): 10–12
Dhalla IA, Anderson GM, Mamdani MM et al. (2002) Inappropriate prescribing before and after nursing home admission. J Am Geriatr Soc 50(6): 995–1000
Fahey T, Montgomery AA, Barnes J et al. (2003) Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 326(7389): 580
Fick DM, Cooper JW, Wade WE et al. (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22): 2716–2724
Flaherty JH (1998) Psychotherapeutic agents in older adults. Commonly prescribed and over- the-counter remedies: causes of confusion. Clin Geriatr Med 14(1): 101–127
Gallagher P, Barry P, O’Mahony D (2007) Inappropriate prescribing in the elderly. J Clin Pharm Ther 32(2): 113–121
Garcia Rodriguez LA and Hernandez-Diaz S (2003) Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure. Epidemiology 14(2): 240–246
Garcia Rodriguez LA and Hernandez-Diaz S (2004) Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 159(1): 23–31
Giron MS, Forsell Y, Bernsten C et al. (2002) Sleep problems in a very old population: drug use and clinical correlates. J Gerontol A Biol Sci Med Sci 57(4): M236–M240
Golden AG, Preston RA, Barnett SD et al. (1999) Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 47(8): 948–953
Goulding MR (2004) Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 164(3): 305–312
Gray SL, Lai KV, Larson EB (1999) Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 21(2): 101–122
Hagen BF, Armstrong-Esther C, Quail P et al. (2005) Neuroleptic and benzodiazepine use in long-term care in urban and rural Alberta: characteristics and results of an education intervention to ensure appropriate use. Int Psychogeriatr 17(4): 631–652
Hanlon JT, Schmader KE, Ruby CM et al. (2001) Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 49(2): 200–209
Hebert C, Delaney JA, Hemmelgarn B et al. (2007) Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf 16(8): 845–849
Hemmeter U, Muller M, Bischof R et al. (2000) Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology (Berl) 147(4): 384–396
Hernandez-Diaz S and Rodriguez LA (2000) Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 160(14): 2093–2099
Holmquist IB, Svensson B, Hoglund P (2003) Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59(8–9): 669–676
Holmquist IB, Svensson B, Hoglund P (2005) Perceived anxiety, depression, and sleeping problems in relation to psychotropic drug use among elderly in assisted-living facilities. Eur J Clin Pharmacol 61(3): 215–224
Huerta C, Varas-Lorenzo C, Castellsague J et al. (2006) Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart 92(11): 1610–1615
Jeste DV, Lacro JP, Palmer B et al. (1999) Incidence of tardive dyskinesia in early stages of low-dose treatment with typical antipsychotics in older patients. Am J Psychiatry 156(2): 309–311
Klotz U (1998) Effect of age on pharmacokinetics and pharmacodynamics in man. Int J Clin Pharmacol Ther 36(11): 581–585
Klotz U, Avant GR, Hoyumpa A et al. (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55(2): 347–359
Kompoliti K and Goetz CG (1998) Neuropharmacology in the elderly. Neurol Clin 16(3): 599–610
Lanctot KL, Best TS, Mittmann N et al. (1998) Efficacy and safety of antipsychotics in behavioral disorders associated with dementia. J Clin Psychiatry 59(10): 550–561
Landi F, Onder G, Cesari M et al. (2005) Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 60(5): 622–626
Landi F, Russo A, Liperoti R et al. (2007) Impact of inappropriate drug use on physical performance among a frail elderly population living in the community. Eur J Clin Pharmacol 63(8): 791–799
Lechevallier-Michel N, Molimard M, Dartigues JF et al. (2005) Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol 59(2): 143–151
Lechin F, van der Dijs B, Benaim M (1996) Benzodiazepines: tolerability in elderly patients. Psychother Psychosom 65(4): 171–182
Martin J, Shochat T, Ancoli-Israel S (2000) Assessment and treatment of sleep disturbances in older adults. Clin Psychol Rev 20(6): 783–805
McShane R, Keene J, Gedling K et al. (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 314(7076): 266–270
Mortimer AM, Shepherd CJ, Rymer M et al. (2005) Primary care use of antipsychotic drugs: an audit and intervention study. Ann Gen Psychiatry 4: 18 DOI:10.1186/1744-859X-4-18
Mulsant BH, Pollock BG, Kirshner M et al. (2003) Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60(2): 198–203
Naranjo CA, Fourie J, Herrmann N et al. (2000) Probing peripheral and central cholinergic system responses. J Psychiatry Neurosci 25(4): 325–336
Ness J, Hoth A, Barnett MJ et al. (2006) Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother 4(1): 42–51
Nomura K, Nakao M, Sato M et al. (2007) The long-term prescription of benzodiazepines, psychotropic agents, to the elderly at a university hospital in Japan. Tohoku J Exp Med 212(3): 239–246
Oborne CA, Hooper R, Swift CG et al. (2003) Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 32(1): 102–108
Panneman MJ, Goettsch WG, Kramarz P et al. (2003) The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study. Drugs Aging 20(11): 833–839
Passaro A, Volpato S, Romagnoni F et al. (2000) Benzodiazepines with different half-life and falling in a hospitalized population: The GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol 53(12): 1222–1229
Paterniti S, Dufouil C, Alperovitch A (2002) Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 22(3): 285–293
Piecoro LT, Browning SR, Prince TS et al. (2000) A database analysis of potentially inappropriate drug use in an elderly medicaid population. Pharmacotherapy 20(2): 221–228
Ray WA, Thapa PB, Gideon P (2000) Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc 48(6): 682–685
Rochon PA, Normand SL, Gomes T et al. (2008) Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 168(10): 1090–1096
Ruths S, Straand J, Nygaard HA (2001) Psychotropic drug use in nursing homes – diagnostic indications and variations between institutions. Eur J Clin Pharmacol 57(6–7): 523–528
Ruths S, Straand J, Nygaard HA (2003) Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 12(3): 176–180
Samsa GP, Hanlon JT, Schmader KE et al. (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 47(8): 891–896
Schneider DL (2002) Insomnia: Safe and effective therapy for sleep problems in the older patient. Geriatrics 57(5): 24–26
Shahar E, Lee S, Kim J et al. (2004) Hospitalized heart failure: rates and long-term mortality. J Card Fail 10(5): 374–379
Snowdon J, Day S, Baker W (2006) Current use of psychotropic medication in nursing homes. Int Psychogeriatr 18(2): 241–250
Sonne J, Loft S, Dossing M et al. (1991) Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects. Br J Clin Pharmacol 31(6): 719–722
Taylor S, McCracken CF, Wilson KC et al. (1998) Extent and appropriateness of benzodiazepine use. Results from an elderly urban community. Br J Psychiatry 173: 433–438
Turnheim K (1998) Drug dosage in the elderly. Is it rational? Drugs Aging 13(5): 357–379
Turnheim K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38(8): 843–853
van der Hooft CS, Schoofs MW, Ziere G et al. (2008) Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 66(2): 276–282
Vitiello MV (1997) Sleep disorders and aging: understanding the causes. J Gerontol A Biol Sci Med Sci 52(4): M189–M191
Wang PS, Bohn RL, Glynn RJ et al. (2001) Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158(6): 892–898
Wick G and Grubeck-Loebenstein B (1997) The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 32(4–5): 401–413
Woerner MG, Alvir JM, Saltz BL et al. (1998) Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 155(11): 1521–1528
Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340(24): 1888–1899
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Midlöv, P., Eriksson, T., Kragh, A. (2009). Inappropriate Drugs in the Elderly. In: Drug-related problems in the elderly. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2446-6_4
Download citation
DOI: https://doi.org/10.1007/978-90-481-2446-6_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2445-9
Online ISBN: 978-90-481-2446-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)